Policy and Legislation
With the new final rules issued Thursday by CMS for accountable care organizations (ACO), the healthcare industry is working to understand the changes, which appear at first glance to make the qualifying parameters more achievable.
The Centers for Medicare & Medicaid Services on Thursday released the final regulations for accountable care organizations (ACOs), which contain major revisions from the draft regulations released earlier this year.
Providers offer options for the Supercommittee to cut Medicare costs by making better coverage decisions and discouraging routine unnecessary services.
Administration officials including Health and Human Service Secretary Kahtleen Sebelius and CMS Administrator Donald Berwick, MD, Tuesday announced new proposed rules to eliminate obsolete and redundant government healthcare regulations that could save hospitals and providers $1.1 billion annually and more than $5 billion over five years.
The deadline for HIPAA 5010 compliance is knocking at the door but there is confusion, even at this late date, about what "readiness" means, says the Healthcare Billing & Management Association (HBMA).
The U.S. Department of Health and Human Services made official on Friday what many had expected: it is dropping its efforts to implement the CLASS Act.
The Health Resources and Services Administration (HRSA) has awarded $3.4 million to programs in 19 states working to improve the system of services for children and youth with special healthcare needs (CYSHCN).
Alternative benefit models rely on cost-sharing approaches for seniors, while some MedPAC members urged benefits that encourage changing unhealthy behaviors.
The U.S. Food and Drug Administration and the Centers for Medicare & Medicaid Services have launched a parallel review pilot program that allows medical devices to be reviewed for approval by the FDA and CMS at the same time.
In light of the record drug shortages currently plaguing U.S. healthcare, Sen. Charles Schumer (D-NY) is calling for a Federal Trade Commission investigation into gray market drug resellers' exorbitant price mark-ups as possible price gouging.